Study Reveals Backup Immune Pathway in mRNA Cancer Vaccines
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Washington University School of Medicine researchers found that mRNA cancer vaccines remained highly effective in mice even when cDC1 dendritic cells — long believed to be the primary driver of the immune response — were missing.
- The Nature study showed cDC2 cells stepped in to activate T cells and eliminate sarcoma tumors in mice lacking cDC1, overturning the assumption that cDC1 was indispensable for mRNA vaccine-triggered anti-tumor immunity.
- Kenneth M. Murphy (senior author) and William E. Gillanders (co-corresponding author) ran the experiments using mice engineered to lack either cDC1 or cDC2 cells, mapping each subtype's contribution to the vaccine response.
- T cells activated by cDC1 and cDC2 each displayed distinct molecular "fingerprints," suggesting the two subtypes play complementary roles and giving researchers new targets for vaccine optimization.
- cDC2 cells activated T cells indirectly through a process called "cross-dressing" — other cells read the mRNA instructions, manufacture the protein fragment, and transfer the membrane complex carrying it to cDC2 for presentation.
- mRNA cancer vaccines are already being tested in trials against melanoma, small cell lung cancer, bladder cancer, and triple-negative breast cancer — the latter vaccine developed by Gillanders himself.
- Gillanders said the work could explain why some patients respond better to mRNA vaccines than others and help guide vaccine formulation, dosing, and strategy for more effective anti-tumor immunity.
Why it matters: Cancer vaccine developers gain two mechanistic targets instead of one — the cDC2 cross-dressing pathway adds a previously invisible route for activating tumor-killing T cells. Researchers now have a concrete biological explanation for variable patient responses, a step toward tailoring vaccines rather than running blind with a single assumed mechanism.
